Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3031 in chemotherapy-induced neutropenia
NCT01923545Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Jul 2010
- Primary completion
- May 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of pegteograstim in neutropenia, sponsored by Dong-A ST. Started Jul 2010; status: completed.
02
Drugs
pegteograstim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01923545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923545.